Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update
10 mai 2016 06h33 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., May 10, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the first quarter...
Bellerophon Reports 2015 Financial Results and Provides Business Update
21 mars 2016 06h03 HE
|
Bellerophon Therapeutics LLC
– Company Receives Final FDA Confirmation to Initiate Phase 3 Studies Using Next Generation INOpulse Device – – Management to Host a Conference Call Today at 8:30 a.m. ET – WARREN, N.J.,...
Bellerophon Therapeutics to Hold Full Year 2015 Financial Results Conference Call on Monday March 21, 2016
14 mars 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., March 14, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will release its full year 2015...
Bellerophon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
04 mars 2016 17h32 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., March 04, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will present in the Cowen and...
Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
02 mars 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., March 02, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported that in connection with the appointment of...
Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer
23 févr. 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Fabian Tenenbaum as Chief...
Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member
16 févr. 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Mary Ann Cloyd as an...
Bellerophon Therapeutics Announces Positive Data From the Final Analysis of the Phase 2 Long-Term Extension Study of INOpulse for Treatment of Pulmonary Arterial Hypertension
09 févr. 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive data from the final analysis of...
Bellerophon to Participate in LEERINK Partners 5th Annual Global Healthcare Conference
03 févr. 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will participate in LEERINK...
Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program
21 janv. 2016 08h03 HE
|
Bellerophon Therapeutics LLC
WARREN, N.J., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that the European Patent Office has...